Naci H, Kesselheim AS - New England Journal of Medicine
The category of “specialty drugs”—high-cost medications requiring special handling—is a unique feature of the US drug pricing system. The authors contrast the US approach with Germany’s value-based negotiation framework that controls drug spending without restricting physician prescribing.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine
Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open